Skip to content

Clinical trials

Phase 2 Multiple Myeloma trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 2 Country / region: Denmark Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20052
20072
20082
20092
20101
20111
20131
20141
20152
20161
20181
20192
20201
20212
20221
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated4
Unknown status4
Active, not recruiting3
Not yet recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Henrik Gregersen3
Vejle Hospital3
Fred Hutchinson Cancer Center2
Janssen Research & Development, LLC2
Nordic Myeloma Study Group2
Thomas Lund2
AbbVie1
Amgen1
Cancer Trials Ireland1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma28
Recurrence4
Neoplasms3
Hodgkin Disease2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myeloid, Acute2
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, Mantle-Cell2
Lymphoma, Non-Hodgkin2
Neoplasms, Plasma Cell2

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.